Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-κB activation in RAW 264.7 cells

International Immunopharmacology

Volumn 9, Issue 3, 2009, Pages 319-323

  Mi Jeong Sung, ^a   Davaatseren, Munkhtugs ^a   Kim, Won ^b   Sung Kwang Park, ^b   Kim, Soon Hee ^a   Haeng Jeon Hur, ^a   Myung Sunny Kim, ^a   Kim, Young Sup ^c   Dae Young Kwon, ^a  

^a Korea Food Research Institute   (South Korea)

^b Chonbuk National University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Inflammation; Macrophage; Mitogen activated protein kinase (MAPK); Nitric oxide; Nuclear factor B (NF B); Vitisin A

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITISIN A;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BENZOFURANS; CELL LINE; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOLS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60549098475     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.12.005     Document Type: Article

References (33)

1. Boissy P., Andersen T.L., Abdallah B.M., Kassem M., Plesner T., and Delaisse J.M. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65 (2005) 9943-9952
2. Goldberg D.M. More on antioxidant activity of resveratrol in red wine. Clin Chem 42 (1996) 113-114
3. Delmas D., Jannin B., and Latruffe L. Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res 49 (2005) 377-395
4. Wang Z., Zou J., Huang Y., Cao K., Xu Y., and Wu J.M. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J (Engl) 115 (2002) 378-380
5. Birrell M.A., McCluskie K., Wong S., Donnelly L.E., Barnes P.J., and Belvisi M.G. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-κB-independent mechanism. FASEB J 19 (2005) 840-841
6. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 126 (1999) 673-680
7. Moon S.O., Kim W., Sung M.J., Lee S., Kang K.P., Kim D.H., et al. Resveratrol suppresses tumor necrosis factor-α-induced fractalkine expression in endothelial cells. Mol Pharmacol 70 (2006) 112-119
8. Ohyama M., Tanaka T., Ito T., Iinuma M., Bastow K.F., and Lee K.H. Antitumor agents 200. Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives. Bioorg Med Chem Lett 9 (1999) 3057-3060
9. Ito T., Akao Y., Yi H., Ohguchi K., Matsumoto K., Tanaka T., et al. Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C. Carcinogenesis 24 (2003) 1489-1497
10. Jang M.H., Piao X.L., Kim H.Y., Cho E.J., Baek S.H., and Kwon S.W. Resveratrol oligomers from Vitis amurensis attenuate β-amyloid-induced oxidative stress in PC12 cells. Biol Pharm Bull 30 (2007) 1130-1134
11. Kim S.H., Park H.S., Lee M.S., Cho Y.J., Kim Y.S., Hwang J.T., et al. Vitisin A inhibits adipocyte differentiation through cell cycle arrest in 3T3-L1 cells. Biochem Biophys Res Commun 372 (2008) 108-113
12. Huang K.S., Lin M., and Cheng G.F. Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes. Phytochemistry 58 (2001) 357-362
13. Arenzana-Seisdedos F., and Virelizier J. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 13 (1983) 437-440
14. Chokri M., Freudenberg M., Galanos C., Poindron P., and Bartholeyns J. Antitumoral effects of lipopolysaccharide, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res 9 (1989) 1185-1190
15. Stuehr D.J., and Marletta M.A. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res 47 (1987) 5590-5594
16. O'Shea J.J., Ma A., and Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2 (2002) 37-45
17. Harris G.K., Qian Y., Leonard S.S., Sbarra D.C., and Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW264.7 cells. J Nutr 136 (2006) 1517-1521
18. Kim H.G., Yoon D.H., Kim C.H., Shrestha B., Chang W.C., Lim S.Y., et al. Ethanol extract of Inonotus obliquus inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells. J Med Food 10 (2007) 80-89
19. Zhao Q., Shepherd E.G., Manson M.E., Nelin L.D., Sorokin A., and Liu Y. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 280 (2005) 8101-8108
20. Ajizian S.J., English B.K., and Meals E.A. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179 (1999) 939-944
21. Dong Z., O'Brian C.A., and Fidler I.J. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J Leukoc Biol 53 (1993) 53-60
22. Sung M.J., Kim W., Ahn S.Y., Cho C.H., Koh G.Y., Moon S.O., et al. Protective effect of α-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Circ Res 97 (2005) 880-890
23. Nussler A.K., and Billiar T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54 (1993) 171-178
24. Park E., Schuller L.G., and Quinn M.R. Taurine chloramines inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154 (1995) 4778-4784
25. Keller R., Keist R., and Frei K. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages. Eur J Immunol 20 (1990) 695-698
26. Xie W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
27. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2 (2001) 907-916
28. Wu C.H., Chen T.L., Chen T.G., Ho W.P., Chin W.T., and Chen R.M. Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages. J Trauma 55 (2003) 540-545
29. Monick M.M., Carter A.B., Flaherty D.M., Peterson M.W., and Hunninghake G.W. Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J Immunol 165 (2000) 4632-4639
30. Xagorari A., Roussos C., and Papapetropoulos A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 136 (2002) 1058-1064
31. Watters J.J., Sommer J.A., Pfeiffer Z.A., Prabhu U., Guerra A.N., and Bertics P.J. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1β production. J Biol Chem 277 (2002) 9077-9087
32. Kao S.J., Lei H.C., Kuo C.T., Chang M.S., Chen B.C., and Chang Y.C. Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 115 (2005) 366-374
33. Tebo J.M., Chaoqun W., Ohmori Y., and Hamilton T.A. Murine inhibitory protein-kappa B alpha negatively regulates kappa B-dependent transcription in lipopolysaccharide-stimulated RAW 264.7 macrophage. J Immunol 153 (1994) 4713-4720